Global NGS Market Forecasted To Grow 15% YoY, To Reach ~$9.3B By 2025 – DeciBio Consulting Market Report

THE ANGELS–(COMMERCIAL WIRE)–DeciBio Consulting LLC’s latest market report, “Next Generation Sequencing (NGS) Market Size, Growth, and Trends (2019-2025),” predicts the Next Generation Sequencing market to grow to ~$9.3k million (USD) by 2025 driven primarily by clinical adoption in oncology settings throughout the patient journey, including early detection and follow-up.

this 8^the Published to provide granularity into the “post-pandemic” market landscape, the edit report incorporates the latest NGS trends and updates past market trends for each market segment, while reassessing the potential for high-growth applications. The market numbers provided are updated using secondary research and the latest trends up to Q3 2022 in light of various factors.

DeciBio co-founder and lead author of the report, Stephane Budel, said: “We have been monitoring the NGS manufacturer market for over a decade, and I am particularly excited about 2023! Many applications, such as MRD and early cancer detection, are gaining traction, and the competitive landscape is more dynamic than ever. NGS is unstoppable. This technology will continue to transform the diagnostic tools and space and drive disruption in precision medicine and shape the future of healthcare.”

Next generation sequencing (NGS) has transformed the landscape of life sciences and diagnostics. This technology is used for applications including human whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing using panels of a few to thousands of genes and expression profiling (eg, RNA -I know that). 2022 turned out to be another anomaly, with many factors contributing to a relatively weak year for a market with a long history and strong growth prospects across multiple applications. Looking over the next 3 years, despite a challenging macroeconomic environment and falling cost per gigabyte, we forecast growth of ~15% per year (vs. 13% in the last 3 years).

Report Methodology / Scope:

Report details
search methods	primary research secondary research
2025 Market Size	$9.3 billion
CAGR (2022 – 2025)	fifteen%
base year	2022 (current)
forecast period	2022-2025
Market/Forecast Currency	American dollar
Report Coverage	Market size, segmentation and forecast; key market players and trends; tests and technologies; market drivers and moderators; competitive analysis; appointments from clinical and research stakeholders
segments covered	Customers: basic academic research, population studies, biopharmaceutical R&D, biopharmaceutical clinical trials, liquid biopsy clinical trials, clinical diagnostic-oncology, clinical diagnostic-NIPT, clinical diagnostic-all others, liquid biopsy-Dx, applied markets, industry , epidemiology (including SARS -CoV-2) Types of products: Instruments (including software) and Reagents (including consumables) Applications: Human WGS, WES, Targeted Resequencing, RNA-Seq, Others Therapeutic Areas: Genomics, Oncology, Infectious Diseases, Method Development and Others geographies: US, Europe, China, APAC and ROW

Learn more about the eighth edition of DeciBio’s Next Generation Sequencing Market Report: https://www.decibio.com/market-reports/next-generation-sequencing-ngs-market-assessment-report

Next-generation sequencing companies mentioned:

• illuminate

• Thermo Fisher (Ion Torrent)

• Roche

• Pacific Biosciences

• Oxford Nanopore

• BGI/MGI

• biological element

• unique genomics

• latest genomics

• QIAGEN

• agilent

• NEBRASKA

• Archer Dx

About DeciBio:

DeciBio Consulting (www.decibio.com) is the leading strategic consulting, market intelligence and SaaS firm dedicated to accelerating the adoption and impact of technologies that enable precision medicine.

Headquartered in Los Angeles, California, DeciBio serves a global client and customer base, ranging from startups to Fortune 500 healthcare corporations. DeciBio provides advisory services for growth planning, market and opportunity assessment, strategy product and portfolio reviews, voice of customer feedback, technology assessment, and business due diligence.